Rising demand for pharma services drives SFW to buy Sannova

Shortened drug development cycle heightens demand for 'high-quality, accurate and efficient testing,' said SFW’s Roger Freeman.

SFW Capital Partners will announce later this morning that the Rye, New York-based private equity firm has completed a majority strategic investment in Somerset, New Jersey-based Sannova Analytical, a contract research organization that provides services to pharmaceutical and biotech companies.

Share this